Corticosteroids and corticotrophin in the treatment of neurologic disorders, with emphasis on neurologic disorders of childhood.
D000305:Adrenal Cortex Hormones / Q000494:pharmacology / Q000627:therapeutic use*; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000009:adverse effects; D001696:Biomechanical Phenomena; D001921:Brain / Q000000981:diagnostic imaging; D001929:Brain Edema / Q000188:drug therapy; D002490:Central Nervous System / Q000293:injuries; D002524:Cerebellar Ataxia / Q000188:drug therapy; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D003882:Dermatomyositis / Q000188:drug therapy; D005158:Facial Paralysis / Q000188:drug therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009157:Myasthenia Gravis / Q000188:drug therapy; D009207:Myoclonus / Q000188:drug therapy; D009422:Nervous System Diseases / Q000188:drug therapy*; D009423:Nervous System Neoplasms / Q000188:drug therapy; D009902:Optic Neuritis / Q000188:drug therapy; D011559:Pseudotumor Cerebri / Q000188:drug therapy; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy; D014057:Tomography, X-Ray Computed
D000305:Adrenal Cortex Hormones; D000324:Adrenocorticotropic Hormone